
A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “Our findings suggest that different strategies may need to be explored in patients… read on > read on >